202 related articles for article (PubMed ID: 19002459)
21. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.
Daniel JM; Dutzmann J; Bielenberg W; Widmer-Teske R; Gündüz D; Hamm CW; Sedding DG
Basic Res Cardiol; 2012 May; 107(3):261. PubMed ID: 22418922
[TBL] [Abstract][Full Text] [Related]
22. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
[TBL] [Abstract][Full Text] [Related]
23. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Heimberger AB; Kong LY; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Wei J; Qiao W; Schmittling RJ; Archer GE; Sampson JH; Hiraoka N; Priebe W; Fuller GN; Sawaya R
Clin Neurosurg; 2009; 56():98-106. PubMed ID: 20214040
[No Abstract] [Full Text] [Related]
24. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
Shen L; Ciesielski M; Ramakrishnan S; Miles KM; Ellis L; Sotomayor P; Shrikant P; Fenstermaker R; Pili R
PLoS One; 2012; 7(1):e30815. PubMed ID: 22303460
[TBL] [Abstract][Full Text] [Related]
25. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
26. Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.
Wang W; Edington HD; Rao UN; Jukic DM; Radfar A; Wang H; Kirkwood JM
Clin Cancer Res; 2008 Dec; 14(24):8314-20. PubMed ID: 19088050
[TBL] [Abstract][Full Text] [Related]
27. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
28. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
Tsujita Y; Horiguchi A; Tasaki S; Isono M; Asano T; Ito K; Asano T; Mayumi Y; Kushibiki T
Oncol Rep; 2017 Oct; 38(4):2197-2204. PubMed ID: 28849140
[TBL] [Abstract][Full Text] [Related]
29. Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
Huang L; Xu Y; Fang J; Liu W; Chen J; Liu Z; Xu Q
Front Immunol; 2021; 12():654749. PubMed ID: 33936081
[TBL] [Abstract][Full Text] [Related]
30. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Oweida AJ; Darragh L; Phan A; Binder D; Bhatia S; Mueller A; Court BV; Milner D; Raben D; Woessner R; Heasley L; Nemenoff R; Clambey E; Karam SD
J Natl Cancer Inst; 2019 Dec; 111(12):1339-1349. PubMed ID: 30863843
[TBL] [Abstract][Full Text] [Related]
31. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
32. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
[TBL] [Abstract][Full Text] [Related]
33. Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas.
Liu F; Cao J; Wu J; Sullivan K; Shen J; Ryu B; Xu Z; Wei W; Cui R
J Invest Dermatol; 2013 Aug; 133(8):2041-9. PubMed ID: 23344460
[TBL] [Abstract][Full Text] [Related]
34. The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy.
Grabenstatter HL; Del Angel YC; Carlsen J; Wempe MF; White AM; Cogswell M; Russek SJ; Brooks-Kayal AR
Neurobiol Dis; 2014 Feb; 62():73-85. PubMed ID: 24051278
[TBL] [Abstract][Full Text] [Related]
35. Suppression of autophagy augments the radiosensitizing effects of STAT3 inhibition on human glioma cells.
Yuan X; Du J; Hua S; Zhang H; Gu C; Wang J; Yang L; Huang J; Yu J; Liu F
Exp Cell Res; 2015 Jan; 330(2):267-276. PubMed ID: 25220423
[TBL] [Abstract][Full Text] [Related]
36. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
37. Glycyrrhizic acid facilitates anti-tumor immunity by attenuating Tregs and MDSCs: An immunotherapeutic approach.
Juin SK; Ghosh S; Majumdar S
Int Immunopharmacol; 2020 Nov; 88():106932. PubMed ID: 32890791
[TBL] [Abstract][Full Text] [Related]
38. WP1066, a small molecule inhibitor of the JAK/STAT3 pathway, inhibits ceramide glucosyltransferase activity.
Tsurumaki H; Katano H; Sato K; Imai R; Niino S; Hirabayashi Y; Ichikawa S
Biochem Biophys Res Commun; 2017 Sep; 491(2):265-270. PubMed ID: 28739255
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma.
Kupferman ME; Jayakumar A; Zhou G; Xie T; Dakak-Yazici Y; Zhao M; Ju J; Mandal M; Jasser S; Madden T; Myers JN; Priebe W
J Exp Ther Oncol; 2009; 8(2):117-27. PubMed ID: 20192118
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
